
AVITA Medical RCEL
$ 4.84
-2.42%
Annual report 2025
added 02-12-2026
AVITA Medical EV - Enterprise Value 2011-2026 | RCEL
Annual EV - Enterprise Value AVITA Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 166 M | 290 M | 483 M | 219 M | 197 M | 368 M | 360 M | 50 M | 52.9 M | 43.3 M | 27 M | 40.8 M | 47.5 M | 54.5 M | 1.54 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 483 M | 1.54 M | 160 M |
EV - Enterprise Value of other stocks in the Medical devices industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
40.9 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
696 K | - | 3.58 % | $ 2.21 M | ||
|
Alphatec Holdings
ATEC
|
1.91 B | $ 12.53 | -3.62 % | $ 1.88 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
76.6 M | - | - | $ 1.77 B | ||
|
Aziyo Biologics
AZYO
|
89.6 M | - | 1.37 % | $ 20.5 M | ||
|
Lianluo Smart Limited
LLIT
|
655 M | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-5.83 M | - | -5.86 % | $ 30.6 M | ||
|
Bruker Corporation
BRKR
|
3.81 B | $ 38.91 | 1.06 % | $ 5.8 K | ||
|
Cognyte Software Ltd.
CGNT
|
994 M | $ 8.34 | 1.81 % | $ 599 M | ||
|
Conformis
CFMS
|
3.84 M | - | - | $ 16.4 M | ||
|
AdaptHealth Corp.
AHCO
|
3.89 B | $ 9.43 | -2.48 % | $ 1.27 B | ||
|
Apollo Endosurgery
APEN
|
423 M | - | - | $ 475 M | ||
|
Electromed
ELMD
|
170 M | $ 24.19 | -0.41 % | $ 205 M | ||
|
Cardiovascular Systems
CSII
|
595 M | - | 0.15 % | $ 844 M | ||
|
CONMED Corporation
CNMD
|
2.57 B | $ 41.83 | -2.71 % | $ 1.3 B | ||
|
EDAP TMS S.A.
EDAP
|
252 M | $ 4.17 | -2.0 % | $ 155 M | ||
|
Cutera
CUTR
|
421 M | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
70.4 M | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
17.3 M | - | -20.74 % | $ 369 K | ||
|
CHF Solutions, Inc.
CHFS
|
-7.7 M | - | 1.15 % | $ 34.5 M | ||
|
AxoGen
AXGN
|
1.55 B | $ 28.81 | -1.4 % | $ 1.33 B | ||
|
Apyx Medical Corporation
APYX
|
54.4 M | $ 3.25 | -1.66 % | $ 113 M | ||
|
Axonics Modulation Technologies
AXNX
|
2.67 B | - | - | $ 3.31 B | ||
|
Dynatronics Corporation
DYNT
|
13.8 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-53 M | - | - | $ 10.2 M | ||
|
FONAR Corporation
FONR
|
91.5 M | $ 18.48 | -0.3 % | $ 121 M | ||
|
Soliton, Inc.
SOLY
|
-100 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.54 B | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
427 M | - | 0.03 % | $ 1.58 B | ||
|
Second Sight Medical Products
EYES
|
5.82 M | - | -0.97 % | $ 54.4 M | ||
|
Accuray Incorporated
ARAY
|
492 M | $ 0.52 | -0.63 % | $ 53.4 M | ||
|
Misonix, Inc.
MSON
|
-1.79 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
639 M | - | - | $ 111 M | ||
|
Cytosorbents Corporation
CTSO
|
87.4 M | $ 0.81 | 2.41 % | $ 44.1 M | ||
|
Align Technology
ALGN
|
15.2 B | $ 175.06 | -3.9 % | $ 13.1 B | ||
|
Intersect ENT, Inc.
XENT
|
1.02 B | - | - | $ 955 M | ||
|
Butterfly Network
BFLY
|
765 M | $ 3.7 | -8.2 % | $ 783 M | ||
|
BIOLASE
BIOL
|
26.8 M | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
187 B | $ 111.16 | -1.67 % | $ 194 B | ||
|
InMode Ltd.
INMD
|
3.99 B | $ 13.46 | -0.74 % | $ 870 M | ||
|
BioSig Technologies
BSGM
|
9.42 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
111 B | $ 71.3 | -1.26 % | $ 106 B | ||
|
IRadimed Corporation
IRMD
|
629 M | $ 101.75 | -3.2 % | $ 1.29 B | ||
|
IRIDEX Corporation
IRIX
|
65.9 M | $ 1.42 | 0.71 % | $ 22.9 M | ||
|
OrthoPediatrics Corp.
KIDS
|
579 M | $ 17.62 | -4.65 % | $ 413 M | ||
|
Pulmonx Corporation
LUNG
|
347 M | $ 1.61 | 11.81 % | $ 63 M | ||
|
Helius Medical Technologies
HSDT
|
3.7 M | $ 2.29 | -0.87 % | $ 1.39 M | ||
|
Medtronic PLC
MDT
|
152 B | $ 92.96 | -2.76 % | $ 120 B | ||
|
Medigus Ltd.
MDGS
|
11.2 M | - | 10.28 % | $ 55.5 M | ||
|
Edwards Lifesciences Corporation
EW
|
49.3 B | $ 83.96 | -1.48 % | $ 49.1 B |